The global implantable sensors market is anticipated to grow at a considerable CAGR of 8.6% during the forecast period (2021-2027). The market growth is mainly attributed to the increase in self-monitoring sensors across the globe. The importance of implantable sensors has been increasing gradually over the years due to the rise in the innovation of technologies leading to self-monitoring and diagnosis of the patient. Moreover, it enables patients to get notified when any problem rises and leads to early problem identification with real-time data. In addition to this, the outbreak of the COVID-19 pandemic crisis has created the demand for implantable sensors to measure the oxygen level of the patient.
To Request a Sample of our Report on Implantable Sensors Market: https://www.omrglobal.com/request-sample/implantable-sensors-market
The rise in healthcare expenditure with the rise in the cost of medical treatment has shifted the interest of the people towards home-based healthcare services. An increasing rate of chronic diseases across the globe has led to the adoption of implantable sensors and the market has seen a high growth from the past few years. Several government initiatives and policies have also played a vital role in contributing to the growth of the market and providing approvals for the same. For instance, in June 2018, the US FDA had approved the first continuous glucose monitoring (CGM) system which was manufactured by Senseonics, Inc. This was approved by FDA to detect glucose for people above age 18 with diabetes. Such technologies allowing patients to gain better control over their health have led to market growth share for implantable sensors.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Application
- By End-User
- By Types
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
